Feb. 5 at 5:03 AM
$BIOA is doing that “quietly coiling under supply” thing again. It has that “compression + calendar” setup traders actually care about.
TA: price keeps compressing into overhead supply — I’m watching ~
$20–21 as the pivot. Break/hold there on real volume is the trigger.
Filings (not vibes):
• Company just priced an offering: 5.897M shares at
$19.50, with a 30-day option for +0.885M shares.
• Net proceeds estimated ~
$107.6M, earmarked to fund BGE-102 + pipeline work.
• And they laid out a straight catalyst runway: full Phase 1 readout in 1H’26, Phase 2a start in 1H’26, DME POC start mid-’26, 2H’26 data, mid-’27 DME readout.
Dilution is real — but so is the “funded + milestone ladder” effect. Watching for the tape to confirm.
